ARTICLE
8 January 2019

CAFC Holds ITC Must Grant Relief Against Defaulting Respondents Under 19 U.S.C. § 1337(G)(1) In Laerdal Medical Corp. v. ITC

FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Contributor

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is a law firm dedicated to advancing ideas, discoveries, and innovations that drive businesses around the world. From offices in the United States, Europe, and Asia, Finnegan works with leading innovators to protect, advocate, and leverage their most important intellectual property (IP) assets.
In Laerdal Medical Corp. v. International Trade Commission, No. 17-2445, the CAFC reversed the ITC's final determination that Laerdal failed to plead its trade dress infringement claims with adequate detail...
United States Food, Drugs, Healthcare, Life Sciences

In Laerdal Medical Corp. v. International Trade Commission, No. 17-2445 (Fed. Cir. Dec. 7, 2018), the CAFC reversed the ITC's final determination that Laerdal failed to plead its trade dress infringement claims with adequate detail, and vacated the Commission's decision that no relief was warranted for those claims. The CAFC remanded the case for the Commission to determine the appropriate remedy after consideration of public interest concerns.  The CAFC held the use of the word "shall" in 19 U.S.C. § 1337(g)(1) unambiguously requires the Commission to grant relief against defaulting respondents, subject only to public interest concerns if all elements of the statute are satisfied.  This appeal arose from an investigation at the ITC where Laerdal sought an exclusion order covering products such as spine boards, cervical collars, CPR masks, and training manikins.  Further discussion of the decision can be found on Finnegan's Federal Circuit IP Blog.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More